Listing Center Coronavirus FAQs for Nasdaq-listed Companies
Reference Library - Advanced Search


** To make multiple selections, select the first criterion and then press and hold the Ctrl Key **
1- 1 of 1 Search Results for:
Libraries:   FAQs - Listings
Filters:   Exchange Traded Products;
Search   Clear

Expand All
Printer Friendly View
Mailto Link 
Page: 1 of 1
Frequently Asked Questions
  Is there a compliance period for an ETP issuer to cure non-compliance with a continued listing requirement?
Identification Number 1413
When Nasdaq believes that an ETP is not in compliance with a continued listing requirement, Nasdaq will contact the issuer to confirm the underlying facts. Following this initial notification, Nasdaq will draft a deficiency notification, as described in the Rule 5800 Series. The letter generally will be issued within ten business days from the initial contact (following re-confirmation of the non-compliance) and the issuer has 45 calendar days from the date of Nasdaq's letter to submit a plan to regain compliance. Based on this plan, Nasdaq can grant up to 180 calendar days from the date of the deficiency notification for the issuer to cure the deficiency.
Publication Date*: 8/14/2017 Mailto Link Identification Number: 1413
material_search_footer*The Publication Date reflects the date of first inclusion in the Reference Library, which was launched on July 31, 2012, or a subsequent update to the material. Material may have been previously available on a different Nasdaq web site.
Page: 1 of 1
App Store       Google Play       Listing Center Content RSS Feed
The Nasdaq Stock Market, Nasdaq, The Nasdaq Global Select Market, The Nasdaq Global Market, The Nasdaq Capital Market, ExACT and Exchange Analysis and Compliance Tracking system are trademarks of Nasdaq, Inc.
FINRA® and Financial Industry Regulatory Authority, Inc.® are registered trademarks of Financial Industry Regulatory Authority, Inc. OTCBBTM and OTC Bulletin BoardTM are trademarks of FINRA